NovaBay Pharmaceuticals, based in Emeryville, California, specializes in eyecare and wound care products, including the Avenova line and hypochlorous acid solutions for various medical applications. The company went public on October 26, 2007, and employs 24 staff members.
David E Lazar sold 441,325 shares of NBY on 16 October at $0.00 per share, worth a total of $0. They now own 39,925 NBY shares, or a 92% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.